Prestige Consumer Healthcare, Inc. (PBH)
46.64
+0.99
(+2.17%)
USD |
NYSE |
Sep 25, 16:00
46.64
0.00 (0.00%)
After-Hours: 18:44
Prestige Consumer Healthcare Research and Development Expense (Annual)
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| March 31, 2008 | 0.00 |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Supernus Pharmaceuticals, Inc. | 104.13M |
| Structure Therapeutics, Inc. | 225.85M |
| ANI Pharmaceuticals, Inc. | 51.66M |
| Corcept Therapeutics, Inc. | 254.91M |
| Veru, Inc. | 15.59M |